Evidence map›Paper›PMID 25033763›Full record

ArticlePharmaceutical research2015

Nanomagnetic activation as a way to control the efficacy of nucleic acid delivery.

Bartosz F Grześkowiak, Yolanda Sánchez-Antequera, Edelburga Hammerschmid, Markus Döblinger, Dietmar Eberbeck, Anna Woźniak, Ryszard Słomski, Christian Plank, Olga Mykhaylyk

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Bartosz F GrześkowiakInstitute of Experimental Oncology and Therapy Research, KLinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675, Munich, Germany.
Yolanda Sánchez-Antequera
Edelburga Hammerschmid
Markus Döblinger
Dietmar Eberbeck
Anna Woźniak
Ryszard Słomski
Christian Plank
Olga Mykhaylyk
Klinikum rechts der Isar · DEAdam Mickiewicz University in Poznań · PLLudwig-Maximilians-Universität München · DEPhysikalisch-Technische Bundesanstalt · DEUniversity of Life Sciences in Poznań · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo explore the potential of magnetofection in delivering pDNA to primary mouse embryonic fibroblasts (PMEFs) and porcine fetal fibroblasts (PFFs) and investigate an effect of magnetic cell labeling on transfection efficacy.

methodsThe formulation and a dose of the magnetic vector were optimized. The efficacy of the procedure was quantified by vector internalization, transgene expression and cell iron loading upon specific labeling with Ab-conjugated magnetic beads or non-specific labeling with MNPs.

resultsUp to sixty percent of PMEF and PFF cells were transfected at low pDNA doses of 4-16 pg pDNA/cell. Specific labeling of the PMEFs with MNPs, resulted in a 3- and 2-fold increase in pDNA internalization upon magnetofection and lipofection, respectively, that yielded a 2-4-fold increase in percent of transgene-expressing cells. Non-specific cell labeling had no effect on the efficacy of the reporter expression, despite the acquisition of similar magnetic moments per cell. In PFFs, specific magnetic labeling of the cell surface receptors inhibited internalization and transfection efficacy.

conclusionsMagnetic labeling of cell-surface receptors combined with the application of an inhomogenous magnetic field (nanomagnetic activation) can affect the receptor-mediated internalization of delivery vectors and be used to control nucleic acid delivery to cells.

Indexed as

Magnetic FieldsAnimalsCells, CulturedDNADrug CarriersFibroblastsMagnetite NanoparticlesMiceMicroscopy, Electron, TransmissionPlasmidsPrimary Cell CultureStaining and LabelingSurface PropertiesSwineTransfectionDNADrug CarriersMagnetite Nanoparticles

Identifiers

PMID25033763
OpenAlexW2032806602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.